Rate My Professor Mary Chavez

Mary Chavez, PharmD, is a Professor in the School of Pharmacy at the University of Texas at El Paso (UTEP). She earned her Doctor of Pharmacy degree from Purdue University. Chavez has held key leadership roles, including Associate Dean for Academic Affairs in the School of Pharmacy, where she contributed to program accreditation, experiential education, and faculty development. She is a Fellow of the American College of Clinical Pharmacy (FAACP) and teaches courses such as Principles of Drug Action, Integrated Pharmacy Skills-Based Practice, and topics on medicinal chemistry and herbal products. Her expertise encompasses drug information, patient safety, clinical pharmacy, pharmacy education, and medical pharmacology.

Chavez's scholarly work centers on the safety and efficacy of dietary supplements, herbal medicines, and drug-herbal interactions. She has co-authored influential United States Pharmacopeia (USP) reviews, including 'Safety of green tea extracts: a systematic review by the US Pharmacopeia' (Drug Safety, 2008), 'United States pharmacopeia safety evaluation of Spirulina' (Critical Reviews in Food Science and Nutrition, 2011), 'United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity' (Menopause, 2008), and 'The state of dietary supplement adverse event reporting in the United States' (Pharmacoepidemiology and Drug Safety, 2008). Other significant publications include 'Evidence-based drug–herbal interactions' (Life Sciences, 2006), 'Valdecoxib: a review' (Clinical Therapeutics, 2003), 'Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis' (Alternative Therapies in Health & Medicine, 2010), 'SAMe: S-adenosylmethionine' (American Journal of Health-System Pharmacy, 2000), and 'Saint John's wort' (Hospital Pharmacy, 1997). She has also published on curricular reform in pharmacy education, such as 'Identifying opportunities for PharmD curricular reform by surveying student pharmacists about career preparedness and exposure' (2020). Her contributions have advanced evidence-based standards for supplement monographs in the USP-National Formulary and informed clinical practices on supplement safety and interactions.